Results 21 to 30 of about 523,804 (280)

Cardiovascular complications in coronavirus disease-2019 patients

open access: yesThe Indian Anaesthetists' Forum, 2023
Background and Aims: Cardiovascular (CV) complications of coronavirus disease 2019 (COVID-19) are neither well-defined nor comprehensively characterized.
Nirav Parikh   +8 more
doaj   +1 more source

Cardiovascular complications of cushing’s syndrome

open access: yesSri Lanka Journal of Diabetes Endocrinology and Metabolism, 2017
Cushing’s syndrome (CS) is a condition caused by chronic exposure to excess glucocorticoids. Mortality rates are four times higher in CS than in the normal population and myocardial infarction, stroke, congestive heart failure and venous thromboembolic ...
H. M. D. P. K. Senevirathna
doaj   +1 more source

Cardiovascular Complications of Prostate Cancer Treatment

open access: yesFrontiers in Pharmacology, 2020
Treatment of prostate cancer (PC) is a rapidly evolving field of pharmacology research. In recent years, numerous novel therapeutics that improve survival and ameliorate disease control have been approved.
Michał Wilk   +2 more
doaj   +1 more source

SARS-CoV-2-related cardiovascular complications in the tropics

open access: yesTropical Medicine and Health, 2022
One of the organs affected by SARS-CoV-2 is the heart. Cardiac manifestations of SARS-CoV-2 include acute coronary syndrome, endocarditis, myocarditis, pericarditis with pericardial effusion, heart failure, Takotsubo syndrome, arrhythmias, intra ...
Josef Finsterer, Sounira Mehri
doaj   +1 more source

Cardiovascular complications associated with chemotherapy

open access: yesUniversidad Médica Pinareña, 2020
Cardiovascular complications associated with ...
Elys María Pedraza-Rodríguez   +3 more
doaj   +2 more sources

Prevalence of Cardiovascular Comorbidities in Patients with Rheumatoid Arthritis

open access: yesMedicina, 2023
Background and Objectives: The risk of developing cardiovascular diseases (CVD) in patients suffering from rheumatoid arthritis (RA) is two times higher compared to the general population.
Marius Rus   +10 more
doaj   +1 more source

Lifestyle Behaviors and Cardiotoxic Treatment Risks in Adult Childhood Cancer Survivors

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Higher doses of anthracyclines and heart‐relevant radiotherapy increase cardiovascular disease (CVD) risk. This study assessed CVD and CVD risk factors among adult childhood cancer survivors (CCSs) across cardiotoxic treatment risk groups and examined associations between lifestyle behaviors and treatment risks.
Ruijie Li   +6 more
wiley   +1 more source

Cardiovascular Disorders in Thyrotoxicosis of Various Origins: Optimization of Treatment Approaches

open access: yesMìžnarodnij Endokrinologìčnij Žurnal, 2014
We have found that in patients with overt hyperthyroidism, pathological remodeling of the left ventricle was found in 30.1 % of cases. The most common type of pathological remodeling was eccentric left ventricular hypertrophy (18.2 %).
А.Yu. Babenko
doaj   +1 more source

Changes in Body Composition in Children and Young People Undergoing Treatment for Acute Lymphoblastic Leukemia: A Systematic Review and Meta‐Analysis

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Ongoing evidence indicates increased risk of sarcopenic obesity among children and young people (CYP) with acute lymphoblastic leukemia (ALL), often beginning early in treatment, persisting into survivorship. This review evaluates current literature on body composition in CYP with ALL during and after treatment.
Lina A. Zahed   +5 more
wiley   +1 more source

Ventilatory efficiency is superior to peak oxygen uptake for prediction of lung resection cardiovascular complications.

open access: yesPLoS ONE, 2022
IntroductionVentilatory efficiency (VE/VCO2 slope) has been shown superior to peak oxygen consumption (VO2) for prediction of post-operative pulmonary complications in patients undergoing thoracotomy.
Andrej Mazur   +8 more
doaj   +1 more source

Home - About - Disclaimer - Privacy